Dr Reddy's in collaboration with SkyePharma on delivery system

Dr Reddy's in collaboration with SkyePharma on delivery system


Using two of SkyePharma's unique drug delivery systems, the UK company SkyePharma has agreed to conduct a feasibility study on an unnamed product with Dr Reddy's Laboratories of India.


The study's expenses will be covered by Dr. Reddy's, and SkyePharma will also get a "small" up-front payment, according to the two businesses. Full development activities would start later this year, they stated, if the feasibility study is successful. 


With organizations like GlaxoSmithKline, Roche, Schiele, Novartis, AstraZeneca, Nitec, and Abbott in the past, SkyePharma has collaborated on the development of both licensed pharmaceuticals as well as drugs in development that use the oral, inhalation, and topical drug delivery technologies of the UK company. 


The FDA recently requested a second clinical study to gather additional efficacy data on the bronchodilator/steroid combination found in SkyePharma's proprietary non-CFC metered-dose aerosol inhaler, which resulted in the announcement that the planned new drug application (NDA) for Flutiform in the US would be delayed.

Comments

Popular posts from this blog

 Role of Blockchain in Healthcare Data Management

Demystifying AI in Drug Discovery: Transforming Pharma R&D

GREEN INITIATIVES IN INDIA : Sustainable Practices in Pharmaceuticals